| Literature DB >> 26286334 |
Yong Chul Lee1, Seung Bum Kim2, Su Jin Gang3, Seung Yong Park4, So Ri Kim5.
Abstract
BACKGROUND: Mycobacterium lentiflavum (M. lentiflavum), a slow growing nontuberculous mycobacterium (NTM), has recently been described as an emerging human pathogen regardless of the immune status of the host. Previous reports have demonstrated that cervical lymphadenitis of children is the most frequent pathology of M. lentiflavum. However, there are little reports regarding pulmonary diseases by M. lentiflavum specifically in immunocompetent patients. CASEEntities:
Mesh:
Year: 2015 PMID: 26286334 PMCID: PMC4544810 DOI: 10.1186/s12879-015-1100-z
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 1Chest X-ray and chest computed tomography (CT) findings in M. lentiflavum-infected patient. Chest Radiography (a; posteroanterior view, b; left decubitus view) shows consolidative lesion in the left lower lobe with fluid shifting sign. Chest CT scan revealed that solid consolidative lesion occupied the left lower lobe with air-bronchogram (c and d). Despite of the antibiotics therapy, the radiologic features were aggravated showing abscess formation in the left lower lobe, accompanying left pleural effusion and newly developed pneumonic infiltrative lesion on the right middle lobe (e and f)
Fig. 2Serial chest imaging findings in M. lentiflavum-infected patient. At 12 month follow-up, chest imaging studies revealed that the previous lesions in both lungs were improved remarkably (a-c). In addition, serial chest CT scans showed the distinct bronchiectasis and multiple small nodular lesions with a tree-in-bud pattern were scattered in the left lingular segment and the left lower lobe (d and e)